nakamura R, Rauchman M. A mouse model of Townes-Brocks syndrome expressing a truncated mutant Sall1 protein is protected from acute kidney injury.
-It has been postulated that developmental pathways are reutilized during repair and regeneration after injury, but functional analysis of many genes required for kidney formation has not been performed in the adult organ. Mutations in SALL1 cause Townes-Brocks syndrome (TBS) and nonsyndromic congenital anomalies of the kidney and urinary tract, both of which lead to childhood kidney failure. Sall1 is a transcriptional regulator that is expressed in renal progenitor cells and developing nephrons in the embryo. However, its role in the adult kidney has not been investigated. Using a mouse model of TBS (Sall1 TBS ), we investigated the role of Sall1 in response to acute kidney injury. Our studies revealed that Sall1 is expressed in terminally differentiated renal epithelia, including the S3 segment of the proximal tubule, in the mature kidney. Sall1 TBS mice exhibited significant protection from ischemia-reperfusion injury and aristolochic acid-induced nephrotoxicity. This protection from acute injury is seen despite the presence of slowly progressive chronic kidney disease in Sall1 TBS mice. Mice containing null alleles of Sall1 are not protected from acute kidney injury, indicating that expression of a truncated mutant protein from the Sall1 TBS allele, while causative of congenital anomalies, protects the adult kidney from injury. Our studies further revealed that basal levels of the preconditioning factor heme oxygenase-1 are elevated in Sall1 TBS kidneys, suggesting a mechanism for the relative resistance to injury in this model. Together, these studies establish a functional role for Sall1 in the response of the adult kidney to acute injury. acute kidney injury; Sall1; Townes-Brocks syndrome; renal hypoplasia; nephrotoxicity EVERY YEAR, ϳ17 MILLION HOSPITALIZED Americans are treated for acute kidney injury (AKI) (6) , with an associated mortality rate as high as 52-80% (3, 7) . Patients that survive AKI have significant associated morbidity and an increase in 30-day mortality after hospital discharge (4, 6, 36, 50) . In the longer term, any incidence of clinically detectable AKI increases the risk for progressive chronic kidney disease (CKD) (6) . Despite the high incidence and complications of AKI, treatment options remain largely supportive due to a lack of understanding of the mechanisms governing repair and recovery from AKI.
Sall1 is a transcriptional regulator that is essential for kidney development (33) . Truncating (nonsense) mutations in SALL1 cause Townes-Brock syndrome (TBS; OMIM 107480), an autosomal dominant congenital disorder that is associated with defects in multiple organs, including the kidney (21) . Missense mutations in SALL1 contribute to a relatively high percentage of nonsyndromic congenital anomalies of the kidney and urinary tract, a common cause of childhood kidney failure (16, 48) . These findings highlight the importance of SALL1 in human kidney development and disease.
Studies in mouse mutants have demonstrated that Sall1 is required to control the balance between self-renewal and differentiation of nephron progenitors during formation of the kidney (2, 18) . It has been postulated that developmental pathways are reutilized in regeneration of adult tissues. However, the role of tissue-restricted transcription factors such as Sall1 in normal cell turnover and in repair/regeneration after injury of differentiated renal epithelia is not well understood. In this study, we investigated the role of Sall1 in the adult kidney in a basal state and in response to acute injury. Our data reveal that Sall1 is expressed in renal tubular epithelia and plays an important role in the protective response to ischemic and toxic insults to the kidney.
METHODS

Mouse strains. Sall1
TBS , Sall1 GFP , Sall1 flox , and ␤-actin-Cre:ER mouse strains have been previously described (14, 19, 42, 53) . The genomic structure of these three Sall1 mutant alleles and their protein products are shown in Fig. 1 . Sall1 TBS and Sall1 GFP mice used in this study are heterozygous mutants. Homozygous mutants of both these strains die in the early postnatal period due to kidney failure as a result of severe renal hypoplasia or agenesis. Sall1 TBS mice produce a truncated Sall1 N-terminal protein which mimics that found in TBS; Sall1 GFP is a null allele that produces green fluorescent protein (GFP) under the control of the Sall1 genomic locus. Sall1 cKO mice were generated by crossing homozygous Sall1 flox/flox mice to ␤-actin-Cre: ER, Sall1 flox/ϩ mice, yielding Sall1 flox/flox ␤-actin-Cre:ERϩ/Ϫ mice. Lactating mothers were administered 5 mg/kg tamoxifen in corn oil by intraperitoneal injection at postnatal day 1 and 2 to activate Cre. Cre-mediated deletion resulted in homozygous postnatal deletion of Sall1 exon 1, thereby creating a null allele; we refer to this allele as Sall1 cKO mice. Deletion of Sall1 was confirmed by quantitative (q) PCR and immunostaining.
AKI. All animal studies were approved by the Veterans Affairs St. Louis Health Care System Institutional Animal Care and Use Committee (IACUC) and conducted in conformity with the Guiding Principles for Research Involving Animals and Human Beings. Renal ischemia-reperfusion injury (IRI) was performed as previously described (11). Eight-week-old male Sall1 mutant mice and wild-type littermates were anesthetized with 2-5% inhaled isoflurane and placed on a homeothermic table to maintain core body temperature at 37°C. The renal pedicles were exposed by midline incision, and renal ischemia was induced bilaterally with microvascular clamps for 30 (severe IRI) or 22 min (moderate IRI). Following ischemia, microvascular clamps were removed, and the change in kidney color was noted to confirm ischemia and reperfusion. Incisions were closed with two layers of sutures, and the mice were administered a 1-l injection of normal saline by intraperitoneal injection, and 0.1 mg/kg buprenorphine, subcutaneously. Sham-operated controls were subjected to an identical procedure without induction of ischemia.
For nephrotoxic injury, 10-wk-old male mice received a single intraperitoneal injection of 5 mg/kg aristolochic acid (AA) in PBS. Vehicle control mice were injected with an equivalent volume of PBS.
Kidney function. Whole blood was obtained by maxillary vein puncture before (day 0, baseline) and after intervention [24 h (day 1) for IRI and 5 days for AA]. Blood was allowed to clot for 20 min, then centrifuged for 10 min to separate the cellular components from the serum. Serum creatinine was measured by HPLC/tandem mass spectrometry performed by the Yale mouse metabolic phenotyping center where indicated or by capillary electrophoresis at the University of Texas Southwestern George M. O'Brien Kidney Research Core. Urine was collected from 10-mo-old mice at a single time point. Urinary albumin and creatinine were measured using a commercial ELISA (Exocell) kit.
Histology. At time of death, mice were perfused with PBS followed by 4% paraformaldehyde (PFA). Right kidneys were collected and fixed with 4% PFA overnight, then dehydrated and embedded in paraffin. Paraffin-embedded sections (Washington University, St. Louis Developmental Biology Histology Core) were stained by periodic acid-Schiff (PAS).
Ten ϫ400 magnification images of the outer medulla (IRI) or cortex (AA) were captured for each animal. Images were coded to facilitate blinded histology scoring. Injury was then assessed by quantifying the number of surviving and necrotic proximal tubules in each micrograph (10) .
Immunofluorescence and Western blot analysis. Eight-week-old male ICR mice were euthanized and perfusion fixed with 4% PFA. Bisected kidneys were then fixed in 4% PFA overnight, dehydrated, and paraffin embedded (Washington University Developmental Biology Histology Core). Four-micrometer sections were rehydrated and subjected to antigen retrieval in 10 mM sodium citrate, pH 6.0, in a rice cooker near 100°C for 1 h. Sall1 was detected independently using antibodies to two different Sall1 epitopes [a mouse monoclonal, R&D (38) and a rabbit polyclonal, 1:1,000 (19) ]. Costaining was performed with biotinylated Lotus tetragonolobus lectin (LTL; 1:200, Vector) or biotinylated Dolichos biflorus agglutinin (DBA; 1:220, Vector). Antibody reactivity was detected using ImmPRESS HRP polymer detection reagent followed by Tyramide-Alexa 488 (1:200, Invitrogen). LTL and DBA were detected using streptaviden-TxRed (1:200, Vector). Slides were counterstained with 4,6-diamidino-2-phenylindole (DAPI) and mounted in Mowiol (Polysciences). To control for nonspecific antibody binding, sections were incubated without primary antibody.
Kidneys isolated from 8-wk-old male wild-type and Sall1
TBS/ϩ mice were mechanically dissociated in 5 ml of 0.5% trypsin, 0.5% collagenase in PBS for 45 min at 37°C. Cells were passed through a 40-m filter and pelleted by centrifugation. Cell pellets were resuspended in hypotonic buffer (20 mM Tris, pH 7.4; 10 mM NaCl; 3 mM MgCl 2) and incubated on ice for 15 min, after which 0.5% NP-40 detergent was added. The lysate was centrifuged, and the pellet was resuspended in complete cell extraction buffer (100 mM Tris, pH 7.4, 100 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10% glycerol, 0.1% SDS), incubated on ice for 30 min with vortexing every 10 min, then centrifuged for 30 min at 14,000 g. Excision by Cre Fig. 1 . Sall1 mutant mouse alleles. Schematic illustrates the different Sall1 mutant mouse alleles used in this study. The left column shows the genomic structure of the targeted allele; (roman numerals refer to exon numbers); the middle column shows the protein product, if any, that is produced by the targeted allele; the column on the right lists the name of the allele as it is referred to in the text. Sall1 TBS was created by insertion of a stop codon in exon 2 corresponding to a common truncating mutation in Townes-Brocks syndrome (TBS) patients, followed by a neomycin selection cassette. This allele produces a 435-amino acid truncated mutant protein that contains the repression domain and the Sall-Sall interaction domain, but not the DNA binding zinc fingers encoded by the C-terminal half of exon 2 and by exon 3. Sall1 GFP was created by replacing exon 2 with a cDNA encoding green fluorescent protein (GFP), followed by a neomycin selection cassette. This allele is a functional null (complete loss of function), and it produces GFP under control of the Sall1 genomic locus. Sall1 flox was created by inserting loxP sites (black triangles) flanking exon 1. Sall1 cKO was generated by cre-mediated excision of floxed exon 1, creating a complete null (loss-of-function) allele which produces no protein product.
was detected by Western blotting (ab52947, Abcam). Western blot quantification was performed by densitometry using ImageJ software.
Proliferation and apoptosis. Proliferation was measured by the incorporation of bromodeoxyuridine (BrdU) into proliferating nuclei. Three hours before death, mice were administered 100 mg/kg BrdU by intraperitoneal injection. BrdU incorporation was visualized by indirect immunofluorescence. Frozen sections were heated to 100°C in 10 mM sodium citrate, pH 6.0, before incubation with a monoclonal antibody to BrdU (MAB3424, Millipore). Apoptosis was measured by terminal transferase-dUTP-nick-end labeling (TUNEL) assay per the manufacturer's instructions (Millipore).
For each animal, the number of BrdU-or TUNEL-positive cells per high-powered field was counted in 10 ϫ400 magnification images of the outer medulla. Data were expressed as the average number of positive tubule cells per high-powered field.
Quantitative real-time PCR. Total RNA was isolated from injured and control kidneys, and cDNA was synthesized as described (2) . Sequence-specific primers were designed using Primer Express 3.0 (Applied Biosystems) and NCBI Primer-BLAST software (52) . Each experiment was performed with three technical replicates and a minimum of three biological replicates. Error bars represent SE for the biological replicates. Relative expression was calculated using the ⌬⌬Ct method (29) with normalization of all samples to GAPDH.
The following primer pairs were used for qPCR analysis: Gapdh (5=-TGTGTCCGTCGTGGATCTGA-3= and 5=-TTGCTGTTGAAGT-CGCAGGAG-3=); Kim-1 (5=-CATTTCAGGCCTCATACTGC-3= and 5=-ACAAGCAGAAGATGGGCATT-3=); Ngal (5=-TGCAGCCA-GACTTCCGGAGCG-3= and 5=-TGATCCAGTAGCGACAGCCCT-TGG-3=); Sall1 (5=-TGATGTTTGAGCCAGCATGT-3= and 5-AAA-GAATTGAGCGCAGCAC-3=); Adora1 (5=-CAAGATCCCTCTCCG-GTACA-3= and 5=-GGCTTGTTCCACCTCACTCA-3=); Cox2 (Ptgs2; 5=-TGAGTACCGCAAACGCTTCT-3= and 5=-CAGCCATTTCCTTC-TCTCCTGT-3=); Hspa1a (5=-GTGTATTGCACGTGGGCTTT-3= and 5=-AAATCACATCAGCGGGGCA-3=); Arg1 (5=-ATTATCGGAGC-GCCTTTCTC-3= and 5=-CCGTGGTCTCTCACGTCATAC-3=); Nos2 (5=-GCCACCAACAATGGCAACAT-3= and 5=-CGATGCACAAC-TGGGTGAAC-3=); Hmox-1 (5=-CAGAAGAGGCTAAGACCGCC-3= and 5=-GCAGTATCTTGCACCAGGCTA-3=); Cxcl1 (5=-CCCAAAC-CGAAGTCATAGCCA-3= and 5=-CTCCGTTACTTGGGGACACC-3=); Cxcl2 (5=-CCAGACAGAAGTCATAGCCAC-3= and 5=-CTTC-CGTTGAGGGACAGCAG-3=); Ccl2 (5=-CACTCACCTGCTGCTA-CTCA-3= and 5=-GCTTGGTGACAAAAACTACAGC-3=); Il33 (5=-TCCTGTCTGTATTGAGAAACCTG-3= and 5=-TTGCCGGGGAAA-TCTTGGAG-3=); Il1b (5=-GACCCCAAAAGATGAAGGGCT-3= and 5=-TGTGCTGCTGCGAGATTTGA-3=); Tlr4 (5=-TGGTTGCAGAA-AATGCCAGG-3= and 5=-AGGAACTACCTCTATGCAGGGAT-3=); Il6 (5=-CTCTGCAAGAGACTTCCATCC-3= and 5=-TGAAGTCTC-CTCTCCGGACT-3=); Tnfa (5=-GATCGGTCCCCAAAGGGATG-3= and 5=-TGGTTTGTGAGTGTGAGGGTC-3=); and Ifng (5=-GGAGGAACTG-GCAAAAGATG-3= and 5=-GTTGCTGATGGCCTGATTGT-3=). Statistical analysis. All statistical analyses were performed using a paired 2-tailed t-test, with significance determined at the P Ͻ 0.05 level.
RESULTS
Sall1
TBS mutant mice exhibit CKD. We previously demonstrated that a mouse model of TBS (Sall1 TBS ) recapitulates the autosomal dominant human phenotypes, with renal hypoplasia apparent in mid-to late gestation embryos (19) . Studies in rodent models and human epidemiological studies strongly support the conclusion that a congenital nephron deficit predisposes to CKD (30) . Because Sall1 TBS mice exhibit congenital renal hypoplasia, we examined these mice at several postnatal time points to determine whether they developed CKD. We found that kidney weights adjusted for body weights were reduced in 2-mo-old Sall1 TBS heterozygous mice compared with wild-type littermate controls (Fig. 2, A and B) . This was accompanied by a 29% higher serum creatinine (sCr) (P Ͻ 0.01, Fig. 1D ), and a significant increase in albumin excretion (25.5 Ϯ 2.3 vs. 17.4 Ϯ 1.6 g/mg Cr, P ϭ 0.011, n ϭ 8) in Sall1 TBS heterozygotes. However, because body weight was reduced in the Sall1 TBS mice compared with wild-type animals ( Fig. 2A) , the reduction in estimated GFR in Sall1 TBS may be greater than suggested by the sCr. Sall1 TBS mice also exhibited two-to fourfold increases in Kim1 and Ngal mRNA at 2 mo of age (Fig. 2C) , suggesting ongoing chronic injury and repair.
To determine whether CKD was progressive, we examined ageing mice. The sCr in Sall1 TBS mice was 52% (P ϭ 0.019, n ϭ 4) higher than wild-type littermates in 6-mo-old animals ( 
min excretion was increased in ageing Sall1
TBS compared with wild-type controls at 10 mo (15.0 Ϯ 1.8 vs. 10.7 Ϯ 1.5 g/mg Cr, P Ͻ 0.05, n ϭ 9), an increase that was similar to that observed in 2-mo-old mice. Together, these results indicate that Sall1 TBS mice have slowly progressive CKD. Sall1 is expressed in the tubular epithelium of the adult kidney. While the nephron deficit present at birth in Sall1 TBS could account for the development of CKD, it is also possible that Sall1 has a role in maintaining renal tubular epithelia after nephron formation has ceased. To address this possibility, we examined Sall1 expression in adult kidneys. At 8 wk of age, Sall1 mRNA was detected by qRT-PCR in the adult kidney, but at levels that are significantly less (ϳ12%) than in the embryonic kidney (Fig. 3A) . To define the localization of Sall1 in the kidney, we performed immunofluorescence microscopy (IF). In the cortex and outer medulla, nuclear Sall1 staining was observed in LTL-positive proximal tubules (Fig. 3B) . Sall1 was also expressed in LTL-negative tubules, but excluded from DBA-positive collecting ducts. This pattern of expression corresponds with the developmental expression of Sall1 in nephron progenitor cells, which give rise to all tubular segments of the kidney except the collecting ducts (2). The specificity of IF for Sall1 was confirmed in kidneys in which Sall1 was deleted (Fig. 3B) . We utilized a Sall1 conditional allele (Sall1 flox ) (53) to bypass the requirement of Sall1 for kidney development. We deleted Sall1 in the early postnatal period using a tamoxifen-inducible Cre to generate adult mice with homozygous deficiency of Sall1 (Sall1 cKO ). In Sall1 cKO kidneys, expression of Sall1 was rarely detected in tubular epithelia, validating the staining in wild-type tissues. We thus conclude that Sall1 expression is maintained in tubular epithelia of the mature kidney in a pattern consistent with its embryonic expression. This finding raised the possibility that Sall1 has a role in the mature adult kidney. TBS mice are protected from IRI. It has been postulated that reactivation of developmental control genes, such as Sall1, in the adult kidney participate in repair and regeneration of tubular epithelium after injury (8, 44) . Moreover, WT and Sall1 TBS (TBS) mice were subjected to moderate (22 min; A-E, n ϭ 18) or severe (30 min; F and G, n ϭ 6) IRI followed by 24 h of recovery. A: periodic acid-Schiff (PAS) staining of kidneys subjected to sham or IRI surgery demonstrating the degree of morphological tubular injury in WT and TBS mice. Also shown is quantitation of proximal tubular necrosis (B), sCr measurements (C), and expression of injury biomarkers Kim1 and Ngal mRNA (D and E) in WT and Sall1 TBS (TBS) kidneys after IRI. F: sCr was increased, but to a significantly less degree in Sall1 TBS (TBS) than WT mice, after severe IRI. G: 83% of the WT mice vs. 17% of Sall1 TBS (TBS) mice subjected to severe ischemia die within 6 days after IRI (n ϭ 6). Day 0 values were obtained just before IRI, day 1, 24 h after IRI. *P Ͻ 0.05. **P Ͻ 0.01. ***P Ͻ 0.001.
CKD, even at the relatively mild-to-moderate degree found in Sall1 TBS , is a risk factor for AKI (49) . We thus hypothesized that Sall1 TBS heterozygous mice would have an increased susceptibility to AKI.
To test this idea, we subjected Sall1 TBS mice to moderate (22 min) and severe (30 min) ischemia followed by reperfusion (IRI). We quantified proximal tubule necrosis in control and mutant mice (Fig. 4, A and B) . While there was morphological evidence of tubular necrosis in Sall1 TBS mice, this was significantly less than in wild-type littermates (51 vs. 72%, P ϭ 0.016, Fig. 4B ). Consistent with the morphological analysis, wild-type mice showed a significant (ϳ3.1-fold) increase in sCr at 24 h after moderate IRI (Fig. 4C) To further evaluate the ability of the Sall1 TBS allele to protect the kidney from AKI, we tested the response to severe (30 min) ischemia. Severe IRI resulted in a Ͼ10-fold increase in sCr in wild-type control mice and 5/6 deaths at days 5-7 after IRI (Fig. 4, F and G) . In Sall1 TBS mice, sCr increased to a significantly lesser degree (4.2-vs. 11.8-fold, P ϭ 0.011), and they exhibited an increased likelihood of survival after severe IRI (1/6 deaths). Thus protection from IRI in Sall1 TBS mice is dose responsive.
In addition to necrosis, apoptosis contributes to loss of tubular epithelial cells after IRI (26, 35) . Sall1 TBS mice subjected to moderate IRI had a 48% reduction in TUNELpositive cells compared with controls (11.5 vs. 22 per HPF, P Ͻ 0.001, Fig. 5, A and B) . Surviving epithelial cells proliferate as part of the regenerative process of the kidney, a response that is already evident 24 -48 h after IRI. Although sCr did not significantly increase in Sall1 TBS mice after moderate injury, there was proximal tubule necrosis and biomarker (Kim-1, Ngal) evidence of injury (Fig. 4, A-E) . Consistent with this observation, we observed increased cell proliferation in injured compared with sham-operated Sall1 TBS mice. However, the proliferative response was significantly greater in wild-type mice after IRI, as would be predicted due to the more severe injury (48 vs. 38 per HPF, P Ͻ 0.001, Fig. 5, C and D) .
TBS mice are protected from nephrotoxic injury. In addition to IRI, nephrotoxic injury to renal tubules is a common cause of AKI. To determine whether Sall1 TBS mice are protected from nephrotoxic injury, we exposed animals to AA, a chem- ical that induces severe AKI in mice and humans (51) . Similar to moderate IRI, sCr was not significantly increased in Sall1 TBS mice after AA exposure, while in wild-type mice Scr increased 4.5-fold (Fig. 6A) . Morphological analysis showed less tubular necrosis in Sall1 TBS compared with wild-type mice (13 vs. 57%, P Ͻ 0.001, Fig. 6 , B and C), indicating protection from nephrotoxic injury.
Protection of TBS mice is not accounted for by Sall1 loss of function. TBS phenotypes result from truncating SALL1 mutations that lead to expression of a mutant protein with dominant effects (13, 19, 20) . Homozygous loss-of-function mutations in SALL1 result in severe renal hypoplasia in mice and humans (2, 45) . To determine whether Sall1 loss of function is responsible for protection from insults that cause AKI, we utilized null and conditional alleles of Sall1. Sall1
GFP is a germline null allele in which GFP is knocked in to the Sall1 genomic locus (42) . At 2 mo of age, sCr was elevated in Sall1 GFP mice compared with wild-type littermates, but to a significantly lesser degree than in age matched Sall1 TBS mice (14 vs. 29%, Fig. 2D ). We subjected Sall1 GFP heterozygous mice to moderate IRI. We found that sCr and proximal tubule necrosis were not significantly different in Sall1 GFP heterozygous mice compared with wildtype controls (Fig. 7, A-C) , indicating that Sall1 haploinsufficiency does not account for protection from IRI. Similarly, these mice were not protected from AA-induced nephrotoxic injury. The percent tubular necrosis in Sall1 GFP mice (60.6.3 Ϯ 8.8, n ϭ 5) was similar to the degree of injury noted in wild-type littermates (61 Ϯ 8.7, n ϭ 5). Consistent with the injury data, there was not a significant difference in sCr between wild-type and Sall1 GFP mice 5 days after exposure to AA (5.1-vs. GFP 4.7-fold compared with pretreatment sCr, P ϭ 0.49, n ϭ 5).
The truncated protein expressed in TBS has the capacity to act as a dominant negative by dimerization with wild-type Sall1 protein (19, 41) . Thus it is possible that Ͼ50% reduction in Sall1 function is required for protection from IRI. To test this idea, we utilized a Sall1 conditional allele (Sall1 flox ) to generate adult mice with homozygous deficiency of Sall1 (Sall1 cKO , Figs. 1 and 3B ). Sall1 cKO kidneys were significantly smaller (0.56 Ϯ 0.04 vs. 0.82 Ϯ 0.04 mg kidney/g body wt ratio, P Ͻ 0.001), and at baseline these mice had a significantly elevated sCr at 2 mo of age compared with wild-type littermates (Fig. 2D) . However, similar to Sall1 GFP , homozygous postnatal deletion of Sall1 did not confer protection after moderate IRI (Fig. 7, D-F) . Together, these results indicate that Sall1 loss of function does not account for protection of Sall1 TBS mice from acute injury to the kidney. The HO-1 preconditioning pathway is induced in TBS mice. Because the protection from ischemic and nephrotoxic insults in Sall1 TBS mice was so dramatic and occurred within 24 h after IRI, we hypothesized that basal gene expression changes in the uninjured state in this Sall1 allele may mediate protection. Transcriptional profiling of nephron progenitor cells from embryonic Sall1 mutant kidneys identified several misregulated genes that have been implicated in ischemic preconditioning (2, 15, 27, 31, 46) . We reasoned that some of these genes would have altered expression in adult Sall1 mutant kidneys and be potential candidates for preconditioning factors. Among these candidates, Heme oxygenase-1 (Hmox-1) mRNA expression in the uninjured kidney was increased 2.3-Ϯ 0.4-fold in Sall1 TBS mice compared with age-matched control littermates (Fig. 8A) . We confirmed the upregulation of Hmox-1 protein by Western blotting (Fig. 8B) . These data suggest that protection of Sall1 TBS mice from acute injury could be due to increased expression of Hmox-1, a preconditioning factor in kidney and other tissues.
HO-1 induction often occurs as a result of cellular stress, such as inflammation (31) . To determine whether Sall1 TBS kidneys exhibited evidence of inflammation, we examined mRNA expression of several cytokines under basal (no acute injury) conditions in 8-to 10-wk-old male mice. We tested factors that are secreted by or regulators of neutrophils (Cxcl1, Cxcl2), macrophages (Ccl2, Arg1, IL1b), Th2 helper T cells (IL33), and innate immunity (Tnfa, Infg, IL6). While some cytokines showed modest changes in expression, only Tnfa exhibited a statistically significant change (31% decrease, P ϭ 0.049) in expression in Sall1 TBS compared with wild-type littermates (Fig. 8C) . However, Infg, IL6, which also modulate innate immunity, did not exhibit altered expression. Expression of inducible nitric oxide synthase (iNos), typically upregulated by oxidative stress, was also not increased in Sall1 TBS kidneys (Fig. 8A) . Together, these results suggest that HO-1 induction in Sall1
TBS is not likely due to chronic inflammatory or oxidative stress.
DISCUSSION
The data presented here identify an important functional role for Sall1 after the kidney has formed. In the adult kidney, we found that Sall1 expression was maintained in renal tubular epithelia derived from multipotent Sall1-positive nephron progenitors, but not in collecting ducts derived from Sall1-negative ureteric buds. Analysis of Sall1 TBS mice from ages 2-18 mo revealed elevated sCr and an increase in albumin excretion and injury biomarkers, providing evidence of CKD. At 2 mo of age, sCr was increased ϳ30% in Sall1 TBS , while in Sall1 GFP heterozygotes the increase in sCr (14%) was significantly less (Fig. 2D) . Sall1 TBS is a dominant allele, which expresses a truncated protein that interferes with wild-type Sall1 function (19, 38) , while Sall1 GFP is a model of haploinsufficiency (34) . Thus the difference between estimated GFR in these two genetic models suggests that a Ͼ50% reduction in Sall1 activity is required to produce both significant renal hypoplasia and CKD. Consistent with this idea, when both copies of Sall1 (Sall cKO ) were deleted in the postnatal period (Fig. 3) , sCr was increased ϳ80% at 2 mo of age, compared with the 30% increase in Sall1 TBS (Figs. 2D, 7F ). Together, these findings suggest a dose-dependent response to the level of wild-type Sall1 protein in the overall function and maintenance of the kidney.
Sall1 TBS and Sall1 cKO mutants exhibit renal hypoplasia due to impaired nephrogenesis (17, 20) . Reduced nephron number at birth is an established risk factor for development of CKD (30) . Moreover, the degree of reduced kidney weight adjusted for body weight (15% for Sall1 TBS vs. 31% for Sall1 cKO ) also correlated with the severity of CKD in these two different Sall1 mutant alleles, as assessed by sCr. A significant proportion of patients with TBS due to dominant mutations in SALL1 develop CKD, with progression to end-stage kidney disease (9, 32, 39) . Based on these observations, we conclude that congenitally reduced nephron number contributes to reduced glo- kidneys measured by qRT-PCR. Cxcl1, C-X-C motif ligand 1; Cxcl2, C-X-C motif ligand 2; Ccl2, C-C motif ligand 2 (also referred to as monocyte chemotactic protein 1; MCP1); Arg1, arginase 1; ILb, interleukin-1␤; IL33, interleukin-33; Tlr4, Toll-like receptor 4; IL6, interleukin-6; Tnfa, tumor necrosis factor-␣; Ifng, interferon-␥. *P Ͻ 0.05. **P Ͻ 0.01. merular filtration in adult Sall1 mutant mice. However, our studies demonstrate a functional role for Sall1 in acute kidney injury, suggesting that in addition to nephrogenesis, Sall1 also has a role in the mature kidney in maintaining the integrity of renal tubular epithelia. In support of this idea is the finding that sCr is modestly increased in Sall1 GFP mice in which overall kidney size is not different from wild-type littermates (Ref. 2 and Rauchman M and Basta J, unpublished observations,). While we cannot exclude a modest reduction in nephron number in Sall1 GFP , it is likely that the significantly elevated sCr in these mice reflects a role for Sall1 in mature renal tubular epithelia.
In response to acute injury, renal tubular epithelia dedifferentiate, proliferate, and then redifferentiate to regenerate tubular epithelia (12, 25) . It has thus been hypothesized that pathways required for kidney development are reutilized for its regeneration. The Wnt and BMP signaling pathways have been shown to mediate the injury and repair responses in the kidney (22, 37, 54) . While many transcriptional regulators have been identified which are essential for kidney development, their role in renal epithelial repair and regeneration is not well understood. Our studies show that a Sall1 mutant allele that is a faithful genetic model of TBS (Sall1 TBS ) confers significant protection from acute ischemic and nephrotoxic injury (Figs. 4  and 6 ). Because we did not find protection with heterozygous or homozygous loss-of-function Sall1 alleles, our studies suggest that the protective mechanism likely depends on a gainof-function or dominant interference mechanism due to expression of a truncated mutant protein from the Sall1 TBS allele. The mutant protein encoded by the Sall1 TBS allele has the potential to interfere with other Sall family members via heterodimerization (19, 41) , suggesting a potential genetic mechanism for the protection from AKI. However, it is unknown whether other Sall proteins (Sall2-4) have a functional role in the adult kidney. Alternatively, the Sall1 mutant truncated protein may exert gain-of-function effects through other pathways that alter the response to injury. Our previous studies have shown that Sall1 TBS heterozygous mice display significant gene expression changes (Rauchman M and Kiefer S, unpublished observations and Ref. 20) . This is often manifested as derepression of Sall1 target gene expression and is thought to be mediated through an interaction between the N terminus of Sall1 and the nucleosome remodeling and decacetylase (NuRD) chromatin remodeling complex (23) . We thus examined candidate Sall1 target genes identified in our studies of kidney development (2), which have also been implicated in ischemic preconditioning. These studies revealed that expression of HO-1, a well-defined preconditioning factor, was selectively upregulated in Sall1 TBS mice before acute injury (Fig.  8) . The degree to which we observed increased HO-1 protein expression is consistent with levels associated with protection from ischemic injury (28, 40) . HO-1 has been shown to protect the kidney, heart, and central nervous system from acute ischemia (15, 27, 31, 47) , indicating the general relevance of this pathway for organ injury and repair. Additional functional studies are needed to define whether elevated HO-1 levels are responsible for the protection from AKI seen in Sall1 TBS mice. In clinical studies, preexisting CKD is thought to represent a risk factor for the severity of AKI and for progression of CKD after episodes of acute injury (4, 5, 43) . Surprisingly, although Sall1 TBS mice have CKD, they are dramatically protected from
AKI. These findings demonstrate that the link between preexisting CKD, reduced GFR, and AKI is not invariable and may depend on the pathobiology associated with specific causes of CKD. Future studies are needed to determine whether the protection from AKI in Sall1 TBS mice is also associated with less fibrosis and protection from CKD progression after severe acute insults. In addition to highlighting the complex role of preexisting CKD on AKI severity, our studies also point to the variable rate of CKD progression. In the case of Sall1 TBS , GFR was reduced by 8 wk of age and renal function declined further in ageing mice at 6 mo. However, we did not observe significant progression of CKD beyond 6 mo when mice were examined up to 1.5 yr of age, within the limitations of using sCr to estimate glomerular filtration rate (GFR). Thus, while Sall1 TBS mice have CKD which is apparent in early adulthood, homeostatic and repair processes are able to preserve function in ageing mice in the absence of superimposed acute or chronic injury. Similar findings have been observed in clinical epidemiological studies. Examination of CKD progression over Ͼ5 years in a large Veterans Affairs cohort noted that while a subset of patients progress rapidly [Ͼ4 ml·min Ϫ1 ·yr Ϫ1 decline in estimated GFR (eGFR)], a significant proportion of patients do not exhibit a decline in eGFR over the same period of longitudinal follow-up (1). These findings underscore the need for further investigation of genetic and environmental factors that determine the rate of CKD progression, beyond the current clinical paradigm (24) .
In summary, we have identified a role for Sall1, a gene essential for kidney development, in the adult kidney. We discovered that Sall1 is expressed in mature adult renal tubular epithelia, and a genetic deficiency of Sall1 leads to CKD. A dominant Sall1 allele that mimics TBS, a human congenital anomaly syndrome, confers dramatic protection from acute ischemic and toxic insults to the kidney. Future studies investigating the mechanism of protection observed in this model could reveal novel therapeutic approaches for AKI.
